Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-05-06

FDA Approved: TRIBENZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Tribenzor, a fixed-dose combination of olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide, from Cose…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRIBENZOR (OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE)

Snippet

SUPPL AP for TRIBENZOR (OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE)